A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison, New York

Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York